Views on cannabis-based medicines for anxiety in autistic people
03 April 2025
This project aims to understand views on cannabis-based medicines for anxiety in autistic people. Participation will involve an online anonymous survey, which takes around 10 minutes to complete. The survey will ask you questions about yourself (for example, age, gender), anxiety symptoms and treatments you have tried, and your views on cannabis-based medicines and the design of a clinical trial to test these medicines.
Requirements
- 18 or above
- Autistic (diagnosed or self-diagnosed)
- Experience anxiety
- Live in England.
Keywords
Ethical approval
This study has been approved by the Health Faculties (Blue) Research Ethics Subcommittee (HR-24/25-45382).
About the researcher
I am a post-doctoral researcher working within the Psychoactive Trials Group at King's College London. My research interests include autism, eating disorders, and psychopharmacology.
